DADE Dade Behring Holdings (MM)

Dade Behring Inc. (NASDAQ:DADE) announced today the launch of the QCC PowerPak� Package-- a performance enhancement tool for Dimension� systems that adds new automated features, allowing more "hands-off" time for clinical laboratory personnel. The Dimension� technology sets the standard in integrated chemistry testing, and it has become the number one global brand, in terms of revenue, in the central laboratory. Now, thousands of Dimension� system users can benefit from time-saving features of the new QCC PowerPak� Package, and therefore increase operational efficiencies in their laboratory. "We are highly focused on meeting the needs of clinical laboratories by offering them efficient and cost-effective products, services and automation solutions that fit their unique needs," said Jim Reid-Anderson, Chairman, President and CEO, Dade Behring. "This new innovation for the Dimension product line is just one more example of Dade Behring's commitment to helping clinical laboratories achieve their goals." The QCC PowerPak� Package has many time-saving features, some of which: Automate quality control (QC) procedures Streamline daily operation processes Enhance patient data management capabilities "The development of the QCC PowerPak is a direct result of Dade Behring listening to our customers and providing them with specific solutions to address their needs," said Rick Lee, Vice President, Global Marketing, Dade Behring. "Chemistry and immunochemistry tests account for the majority of test volume in the clinical laboratory and one of our primary goals is to help clinical laboratories streamline operational activities in this area." The QCC PowerPak� Package is available for current and new Dimension� RxL Max� or Dimension� Xpand� Plus System customers. The product will be shown in the Dade Behring booth at the upcoming American Association of Clinical Chemistry (AACC) Annual Meeting in San Diego, California, July 17-19, 2007. About Dade Behring With 2006 revenue of more than $1.7 billion, Dade Behring is the world's largest company solely dedicated to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of clinical laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at www.dadebehring.com. This press release may contain "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward statements include information regarding the intent, belief or current expectation of the company and members of its senior management team, including, without limitation, expectations regarding prospective performance and opportunities and the outlook for the company's businesses, performance, opportunities and regulatory approval. In addition, the company is in the process of a major new product launch, which involves risks and uncertainties regarding product performance, costs of introduction and support, and customer acceptance. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by the company.